Journal
INTERNATIONAL HEART JOURNAL
Volume 62, Issue 1, Pages 193-196Publisher
INT HEART JOURNAL ASSOC
DOI: 10.1536/ihj.20-442
Keywords
Congestive heart failure; Furosemide; Dyspnea; Cardiac edema; Cardiovascular diseases; Potassium canrenoate
Categories
Ask authors/readers for more resources
Intravenous mineralocorticoid receptor antagonists (MRAs) have been successfully used as a rescue procedure in patients with acutely decompensated heart failure (ADHF) and diuretic resistance. Further trials evaluating the effects of this therapeutic strategy in ADHF could be promising.
Intravenous mineralocorticoid receptor antagonists (MRAs) have been used in some centers for decades to reduce the risk of hypokalemia and boost diuresis in acutely decompensated heart failure (ADHF). We report the well-tolerated use of intravenous MRAs as a rescue procedure in 3 patients admitted for ADHF with important diuretic resistance. Undertaking trials evaluating the effect of this therapeutic strategy in ADHF could represent a promising avenue.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
